about
A novel role for bioactive lipids in stem cell mobilization during cardiac ischemia: new paradigms in thrombosis: novel mediators and biomarkersN-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic ratsAdipose tissue macrophages promote myelopoiesis and monocytosis in obesityInflammation and thrombosis in cardiovascular disease.Lipolysis, and not hepatic lipogenesis, is the primary modulator of triglyceride levels in streptozotocin-induced diabetic mice.Inhibition of matrix metalloproteinase-2 improves endothelial function and prevents hypertension in insulin-resistant rats.Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway.Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: studies in mice and FH childrenHyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats.Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes.Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice.GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats.Withania somnifera improves bone calcification in calcium-deficient ovariectomized rats.Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes.Antioxidant N-acetylcysteine restores systemic nitric oxide availability and corrects depressions in arterial blood pressure and heart rate in diabetic rats.SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr-/- type 1 diabetic mice.Disordered haematopoiesis and cardiovascular disease: a focus on myelopoiesisIt's reticulated: the liver at the heart of atherosclerosisChronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesisCathelicidin Related Antimicrobial Peptide (CRAMP) Enhances Bone Marrow Cell Retention and Attenuates Cardiac Dysfunction in a Mouse Model of Myocardial InfarctionRad GTPase deletion attenuates post-ischemic cardiac dysfunction and remodelingMonocytes, Macrophages, and Metabolic Disease in Atherosclerosis.Gonadectomy prevents endothelial dysfunction in fructose-fed male rats, a factor contributing to the development of hypertensionAntioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic ratsN-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic ratsDefective cholesterol metabolism in haematopoietic stem cells promotes monocyte-driven atherosclerosis in rheumatoid arthritisCharacterizing the Retinal Phenotype in the High-Fat Diet and Western Diet Mouse Models of PrediabetesBone Marrow-Derived Cells Restore Functional Integrity of the Gut Epithelial and Vascular Barriers in a Model of Diabetes and ACE2 DeficiencyS100A8/A9 in Myocardial InfarctionGenetic Deletion of Syndecan-4 Alters Body Composition, Metabolic Phenotypes, and the Function of Metabolic Tissues in Female Mice Fed A High-Fat DietCirculating stem cells and cardiovascular outcomes: from basic science to the clinicNeutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction
P50
Q27690654-8D3C8524-8658-4271-BCF3-0A9326F08DFDQ28573358-E481CEFA-C63F-4704-A5F9-19089120DD46Q33724394-C6E33C39-C35A-4779-9E34-E42B241D40C4Q33864069-BA214385-ACF4-4F27-AFA9-CBD95F9F885DQ34734402-93A295BA-33AD-47BD-9EE7-6B8560DE8BE4Q35859780-A72AB8D1-F313-4AE5-BBBA-E10DEE69CBDBQ36323148-37175EC7-1B16-4B9B-A030-BFA832CF685DQ36951483-B1B46E31-86A8-4D61-8205-7BD3AB6817B2Q37711215-55CF9231-DE2B-44A7-B5BC-066B3B2D930CQ42085364-25342734-8D82-48C3-ADB4-EBA61FC28184Q42180113-9D0760BF-58A7-4D83-955C-91EA4AF2CB83Q42186976-01CADDD9-495C-4001-A48B-6FE0EEE7B394Q43181533-9E569F25-E414-420B-92C0-43940E0D9779Q46282084-2C97A962-3B34-4DC7-8EAD-20682807BFF2Q46592213-B04441D1-D76F-4940-B32F-40C05E9311D9Q46877758-7213731D-850F-4B34-93AF-BBAEDBD2022EQ52666460-00B779AB-8364-41A4-ADD6-494F02522331Q57160541-FF06D4F6-0E15-4B79-9003-6FEFABE8AD03Q57178397-0E9DC8D3-DA44-463F-B6A9-82C83CF4CD07Q58557033-4F1425EF-EA44-475F-8E0F-A7035E29F89EQ61942655-84360109-65E3-4B47-9013-B14833D45EB4Q62815342-5865B341-3C81-40F4-86FF-138EF4FA5EB8Q64966156-45B596BD-D841-4E3B-8F95-53F26CDDDA25Q79827980-916FE19E-B797-4E5A-9B93-767168579B18Q79960840-32078EE1-F862-4962-B6DE-27DE711B8D0FQ83299065-819E3C5A-BFD5-4BC2-A7CE-FEEF0B03DB60Q89113492-9355DDFD-F201-44CE-BA53-25BC4B7D9BEDQ89835099-8BAD52BF-11A7-4893-8AC5-46148F7A461EQ90698406-112B6D6E-8FC8-4953-81E0-C4C56ECC090BQ91313252-FBE80C06-6C77-40D4-BD0A-E1692C792A4DQ91376584-F2C8E48F-311C-4C64-9A29-E360C702C73AQ92349904-A4CCDC40-326B-4628-9EFE-CA458D9CDE68Q92665286-1CC7E565-261E-4FE8-AE04-1AB04CCA0591
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Prabhakara R Nagareddy
@ast
Prabhakara R Nagareddy
@en
Prabhakara R Nagareddy
@es
Prabhakara R Nagareddy
@nl
type
label
Prabhakara R Nagareddy
@ast
Prabhakara R Nagareddy
@en
Prabhakara R Nagareddy
@es
Prabhakara R Nagareddy
@nl
prefLabel
Prabhakara R Nagareddy
@ast
Prabhakara R Nagareddy
@en
Prabhakara R Nagareddy
@es
Prabhakara R Nagareddy
@nl
P108
P106
P31
P496
0000-0002-0294-641X